On April 18, President Donald Trump signed an executive order loosening restrictions on psychedelic drugs. The move clears the way for research into substances that have been illegal under federal law since 1971, when Nixon established the Controlled Substances Act (CSA), classifying psychedelics as high-risk drugs with “no accepted medical use.” The order calls on the Food and Drug Administration to fast-track review of psychedelic drugs like MDMA, LSD , psilocybin, and ibogaine . It also

Tag-uri: Donald Trump